content

U.S. Government Exercises 1st Option for Additional 100 Million Doses of Moderna’s COVID-19 Vaccine Candidate

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced that...

AstraZeneca reports Trixeo Aerosphere approved in EU for COPD maintenance

AstraZenecaโ€™s Trixeo Aerosphere has been approved in the European Union (EU) for maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary...

Roche launches laboratory SARS-CoV-2 antigen test to support high-volume testing of suspected COVID-19 patients

Roche announced that it has launched a high-throughput SARS-CoV-2 antigen test as an aid in the diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2...

SpiceXpress strengthens pharma cold chain capabilities with Om partnership

SpiceXpress, the cargo division of India-based carrier SpiceJet, has partnered with Om Logistics to strengthen its capabilities to transport temperature-sensitive Covid-19 vaccines. The carrier said...

UPS To Support Distribution Of Approved Vaccine As Part Of Operation Warp Speed

UPS announced its involvement and full support of distribution efforts for Pfizer-BioNTechโ€™s COVID-19 vaccine as part of Operation Warp Speed. Pfizerโ€™s and BioNTechโ€™s vaccine,...

FedEx to Ship First Wave of COVID-19 Vaccines Across the United States

FedEx Express, a subsidiary of FedEx Corp. and the worldโ€™s largest express transportation company, announced that operations are in motion to transport its first...

Sanofi, GSK COVID-19 vaccine rollout delayed on low immune response in older adults

Sanofi and GSK announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine program to improve immune response in older adults. Phase 1/2 study...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read